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Abstract
Background: The maintenance of genomic integrity is essential for cell viability. Complex signalling pathways
(DNA integrity checkpoints) mediate the response to genotoxic stresses. Identifying new functions involved in the
cellular response to DNA-damage is crucial. The Saccharomyces cerevisiae SLT2 gene encodes a member of the
mitogen-activated protein kinase (MAPK) cascade whose main function is the maintenance of the cell wall
integrity. However, different observations suggest that SLT2 may also have a role related to DNA metabolism.
Results: This work consisted in a comprehensive study to connect the Slt2 protein to genome integrity
maintenance in response to genotoxic stresses. The slt2 mutant strain was hypersensitive to a variety of genotoxic
treatments, including incubation with hydroxyurea (HU), methylmetanosulfonate (MMS), phleomycin or UV
irradiation. Furthermore, Slt2 was activated by all these treatments, which suggests that Slt2 plays a central role in
the cellular response to genotoxic stresses. Activation of Slt2 was not dependent on the DNA integrity checkpoint.
For MMS and UV, Slt2 activation required progression through the cell cycle. In contrast, HU also activated Slt2 in
nocodazol-arrested cells, which suggests that Slt2 may respond to dNTP pools alterations. However, neither the
protein level of the distinct ribonucleotide reductase subunits nor the dNTP pools were affected in a slt2 mutant
strain. An analysis of the checkpoint function revealed that Slt2 was not required for either cell cycle arrest or the
activation of the Rad53 checkpoint kinase in response to DNA damage. However, slt2 mutant cells showed an
elongated bud and partially impaired Swe1 degradation after replicative stress, indicating that Slt2 could
contribute, in parallel with Rad53, to bud morphogenesis control after genotoxic stresses.
Conclusions: Slt2 is activated by several genotoxic treatments and is required to properly cope with DNA damage.
Slt2 function is important for bud morphogenesis and optimal Swe1 degradation under replicative stress. The
MAPK Slt2 appears as a new player in the cellular response to genotoxic stresses.
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Background
Genome stability and integrity maintenance are funda-
mental tasks in the cellular function. The DNA in each
cell is under constant attack: genomic transactions,
spontaneous chemical changes in DNA constituents,
replication defects, and endogenous and exogenous
agents, inflict damage to DNA. An efficient response to
DNA damage is crucial to maintain cellular viability and
to prevent diseases like cancer. Eukaryotic cells have
developed surveillance mechanisms to respond to geno-
toxic stresses. These are the DNA damage and DNA
replication checkpoints (referred to as DNA integrity
checkpoints), a complex signaling network that coordi-
nates cell cycle progression with DNA repair in
response to DNA damage or defects in DNA replication
to avoid genomic instability [1].
Checkpoint machinery is highly conserved in eukar-
yotes. The major regulators of the DNA-damage
response are the PI3K-related protein kinases ATM
(ataxia-telangiectasia mutated) and ATR (ATM and
RAD3-related) kinases, Tel1 and Mec1, respectively in S.
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distinct functions in maintaining yeast genome integrity.
Tel1 is specific in signaling double-strand breaks
(DSBs). In contrast, Mec1 plays a more general role by
functioning in the response to different types of damage,
including DSBs, base adducts or crosslinks, and func-
tions during the S phase to regulate the firing of replica-
tion origins. Early in the response, Mec1 and Tel1 are
recruited to the sites of DNA damage together with
accessory proteins that provide platforms on which
damage response components are assembled. A final
consequence is that Mec1 and Tel1 phosphorylate and
activate the checkpoint effector kinases Chk1 and Rad53
[6]. Rad53 mediates most of the response in budding
yeast cells. Once phosphorylated, Rad53 is released from
chromatin to act on critical targets that promote cell
cycle arrest. Additionally, Rad53 targets factors to
induce the expression of DNA repair genes, stimulates
deoxyribonucleotide triphosphate (dNTP) production,
suppresses the replication origins firing and stabilizes
replication forks.
In most eukaryotic cells, cell cycle progression is
blocked in response to DNA damage or replication
stress mainly by stimulating inhibitory phosphorylation
of cyclin-dependent kinases (Cdc28 in S. cerevisiae).
This inhibition is controlled by the balance between the
inhibitory Wee1 kinases (Swe1 in S. cerevisiae)a n dt h e
opposite effect of the Cdc25 phosphatases (Mih1 in S.
cerevisiae)[ 7 ] .B u d d i n gy e a s ti sa ne x c e p t i o nb e c a u s e
this biochemical switch doesn o tp l a yar o l ei nr e p l i c a -
tion stress or DNA damage-induced cell cycle arrest.
Instead, this control is the basis of the morphogenesis
checkpoint, a mechanism that delays the mitotic activa-
tion of Cdc28 in response to many environmental stres-
ses that provoke a transient depolarization of the actin
cytoskeleton, which affects bud construction [8,9]. How-
ever, more recent observations have also connected
Swe1 regulation to some aspects of the response to
interrupted DNA synthesis. Swe1 accumulates in hydro-
xyurea-treated cells in a DNA-damage checkpoint inde-
pendent manner preventing Cdc28-associated mitotic
activities. Later on Swe1 degradation is required for
proper recovery from hydroxyurea-induced arrest [10].
Swe1 degradation is triggered by the Mec1-Rad53 DNA-
damage checkpoint cascade and plays also a crucial role
in the control of morphogenetic events during DNA
replication stress [11]. In particular, the DNA-damage
checkpoint triggers the switch from apical to isotropic
bud growth to maintain proper bud morphogenesis.
Actin cytoskeleton dynamics along the cell cycle is con-
trolled by different cyclin-Cdc28 kinases [12,13]. The
switch from apical to isotropic bud growth requires acti-
vation of the mitotic Clb1,2-Cdc28 kinases in the G2
phase. During the response to DNA damage, Mec1-
Rad53 activation causes Swe1 degradation, which allows
to build up Clb1,2-Cdc28 activity to switch off apical
bud growth.
Mitogen-activated protein kinases (MAPK) are at the
core of many signal transduction pathways, orchestrat-
ing specific cellular responses to a wide range of stimuli
[14]. S.cerevisiae cells contain five MAPK that regulate
mating (Fus3), pseudohyphal/invasive growth (Kss1),
sporulation (Smk1), response to high osmolarity (Hog1)
and response to cell wall stress (Slt2) [15]. Slt2 is the
MAPK of the cell wall integrity pathway [16,17]. Slt2 is
a functional homolog of human ERK5 [18], a MAPK
that is activated in response to not only growth factors,
but also physical and chemical stresses [19,20]. In yeast,
Slt2 is activated under conditions that stress the cell
surface, such as growth at high temperatures, hypo-
osmotic shock, polarized growth, actin perturbation, or
the presence of compounds or mutations that interfere
with cell wall biosynthesis [21]. Once activated, Slt2
controls the expression of the genes involved in cell wall
biosynthesis through the regulation of transcription fac-
tors Rlm1 and SBF (Swi4-Swi6) to maintain cell integrity
[22-24]. In addition to gene expression control, Slt2 is
also related to the regulation of actin cytoskeleton polar-
ization [25] and contributes, although partially, to the
mitotic delay induced by Ca
2+ or actin cytoskeleton per-
turbation as part of the morphogenesis checkpoint
mechanism [26,27]. Slt2 is also involved in the cellular
response to oxidative stress through the control of
cyclin C degradation [28]. Cross-talks between MAPK
pathways are common. Thus, the Hog1 kinase (the
functional homolog of mammalian p38 MAPK) has
been recently described to operate with Slt2 in the adap-
tation to zymolyase-mediated cell wall stress [29].
MAPKs have been related to the response to DNA
damage. Mammalian MAPKs are grouped into the ERK,
JNK/SAPK and p38 families [30,31]. Different genotoxic
treatments activate p38, which contributes to the estab-
lishment of cell cycle checkpoints [32]. Activation of
p38 involves the ATM/ATR checkpoint pathway, along
with other mechanisms which are yet to be established.
Activation of ERK and JNK kinases is also induced by
multiple DNA damage stimuli [33-38]. Moreover, both
ERK1 and ERK2 kinases are required for the proper
checkpoint activation by facilitating activation of ATM
and ATR [39-42]. Regarding S. cerevisiae, we previously
showed that Slt2 is activated by hydroxyurea and that
the slt2 mutant is sensitive to this drug [43]. Further-
more, genetic interactions have connected Slt2 to DNA-
damage checkpoint proteins and the response to MMS
[43,44]. Here, we extend our work by carrying out a
comprehensive analysis of the connection of Slt2 MAPK
with the cellular response to different types of DNA
damage caused by a wide range of genotoxic agents.
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The slt2 mutant strain is hypersensitive to genotoxic
agents
Cells must cope with different genotoxic stresses to
guarantee genomic integrity. The nature and form of
action of these genotoxic stresses notably differ. Treat-
ment with hydroxyurea (HU) inhibits ribonucleotide
reductase, causing a depletion of dNTP pools, which
interferes with DNA replication fork progression and
originates subsequent chromosome breakages. Previous
work from our group demonstrated that slt2 mutant
strain growth in the presence of HU is severely affected
[43]. We wondered whether Slt2 could also be related
to other types of DNA damage apart from replication
blockage. To investigate this possibility, slt2 mutant
strain growth was assayed under conditions that induce
the methylation of bases (incubation with alkylating
agent methylmetanosulfonate -MMS-), the covalent
cross-linking of adjacent pyrimidine bases (irradiation
with UV light) or double-strand breaks (incubation with
phleomycin). As Figure 1A illustrates, the slt2 mutant
strain was unable to properly grow when compared to
the wild-type strain, not only in the presence of HU, but
also in the presence of MMS, phleomycin, or even after
UV irradiation. Quantitative survival assays with various
doses of genotoxic treatments confirmed an increased
loss of cell viability in the absence of Slt2 (Figure 1B).
The sensitivity of slt2 cells to genotoxic stress was less
severe than the one observed in the DNA-damage
checkpoint mutant mec1 (Figure 1B). The original
W303-1a strain contains the rad5-535 mutation, which
could contribute to the observed growth defects. There-
fore, growth analysis was also carried out in a RAD5
independent genetic background. As it is shown in Fig-
ure 1C, Slt2 inactivation in the SEY6211 strain also ori-
ginated a reduced cell viability. All these results indicate
that yeast cells need a functional Slt2 MAP kinase to
optimally survive DNA damage, whatever the nature of
the damage, suggesting that Slt2 plays a central role in
the cellular response to genotoxic stress.
Slt2 is activated by genotoxic stresses
Slt2 is activated by phosphorylation in the activation
loop. In previous works, we observed a dramatic
increase in the phosphorylation state of the Slt2 MAP
kinase after addition of hydroxyurea [43]. Here, we
Figure 1 Hypersensitivity of slt2 mutant strain to genotoxic stress. A) 10-fold serial dilutions from exponentially growing cultures of wild
type (W303-1a) and slt2 (JCY1062) strains were spotted onto YPD medium containing 100 mM hydroxyurea, 0.025% MMS or 5 μg/mL
phleomycin or were exposed to UV radiation (35 J/m
2). Plates were incubated at 25°C for 3 days. B) Aliquots from exponentially growing
cultures of wild type (W303-1a), slt2 (JCY1062) and mec1 sml1 (JCY1039) strains were incubated for 90 min. at the indicated doses of HU, MMS
and phleomycin or were exposed to different doses of UV radiation. Cells were plated on YPD and the percentage of surviving cells relative to
untreated controls was determined. C) Aliquots from exponentially growing cultures of wild type (SEY6211) and slt2 (JCY193) strains were
incubated in the presence of 0.4 M HU, 0.02% MMS, 5 μg/mL phleomycin for 1 hour or were exposed to UV radiation (10 J/m
2). Cell survival
relative to untreated controls was determined.
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DNA damage also cause Slt2 activation. First, W303-1a
cells were treated with HU or MMS, or were irradiated
with different UV doses to induce DNA damage. Occur-
rence of damage was monitored by analyzing the phos-
phorylation state of the checkpoint kinase Rad53. The
appearance of lower Rad53 electrophoretic mobility
bands corresponding to the phosphorylated protein con-
firmed that the checkpoint was activated by these treat-
ments. It is interesting to note that higher levels of
phosphorylated Slt2 were detected in these cells, indicat-
ing that the MAP kinase Slt2 is activated in those cells
incubated in the presence of HU or MMS, or those
exposed to UV radiation (Figure 2). A similar result was
obtained in a W303-derived RAD5 strain and in the
SEY6211 genetic background (Figure 2). Slt2 activation
was also observed after induction of double-strand
breaks (DSB) with phleomycin. Next, we analyzed the
response to a single DSB induced by the addition of
galactose to raffinose-grown cells expressing the HO
endonclease under GAL1 promoter control. As Figure 2
depicts the levels of phosphorylated Slt2 drastically
increased after the induction of a single DSB. This in
not due to the change in carbon source since Slt2 acti-
vation after addition of galactose is not observed in a
wild type control strain. All these observations are con-
sistent with the above-described slt2 mutant hypersensi-
tivity to genotoxic stresses and indicate that Slt2
activation is a crucial step in the cellular response to all
kinds of DNA damage. Interestingly, Slt2 activation by
genetic stresses is mostly, if not totally, mediated by a
post-translational mechanism since Slt2 protein level is
not significantly affected (Figure 2, 4 and 5).
Slt2 is involved in cell wall biosynthesis. It is activated
by cell surface stress to maintain cell integrity. To
investigate whether the activation of Slt2 by genotoxic
stresses is a direct response to damage or an indirect
effect caused by the morphogenetic stress deriving from
genotoxic treatments, we repeated the experiments in
cells grown in the presence of an osmotically stabilized
agent (sorbitol). The results showed that both the hyper-
sensitivity of slt2 cells to (Figure 3A) and Slt2 activation
by (Figure 3B) HU, MMS, phleomycin and UV radiation
also occur in the presence of sorbitol. These results
further reinforce a direct connection of Slt2 to the DNA
damage response.
Analysis of Slt2 activation in DNA-damage checkpoint
mutants
The cellular response to genotoxic stress is governed
by the DNA integrity checkpoint pathway. We won-
dered whether Slt2 activation by genotoxic stresses was
mediated by the DNA damage checkpoint. To investi-
gate this, activation of Slt2 by HU or MMS was ana-
lyzed in the mutant strains in checkpoint upstream
kinases Mec1 and Tel1 or in the effector kinase Rad53
(Figure 4). Rad53 and Mec1 are essential genes so we
used in these cases strains containing the sml1 muta-
tion, which is known to suppress rad53 and mec1 leth-
ality. It is noteworthy that strong Slt2 activation took
place in the absence of genotoxic agents in rad53 and
mec1 tel1 mutant strains. This is in agreement with
previously reported results and is probably a response
to the cell morphology and cell wall defects character-
istic of these checkpoint kinase mutants [11]. Another
important aspect is that incubation with HU or MMS
brought about higher levels of activated Slt2 in the
tel1, mec1, mec1 tel1 or rad53 mutant cells. A similar
result was obtained with the tetO7:RAD53 mutant
strain. These results demonstrate that Slt2 activation
Figure 2 Activation of Slt2 MAP kinase by genotoxic stress. Exponentially growing cultures of the wild type W303-1a and SEY6211 strains
were split and incubated for 60 min in the absence or presence of 200 mM hydroxyurea, 0.04% MMS, 5 and 10 μg/mL phleomycin, or were
irradiated with different doses of UV radiation as indicated. Cultures of the GAL1:HO (JKM139) mutant strain grown on rafinose were split and
incubated for 4 hours after the addition of glucose or galactose up to 2%. The level of Slt2 phosphorylated in the activation loop and total Slt2
protein in cell extracts was determined by western analysis. Analysis of chekpoint kinase Rad53 activation is shown as a control of the presence
of genotoxic stress. Ponceau staining of the membranes are shown as loading control.
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damage checkpoint.
Slt2 is activated by HU in post-replicative cells
As the response to genotoxic stress varies depending on
the cell cycle stage [45-48], we wondered whether Slt2
activation in response to genotoxic agents depends on
the cell cycle stage. Accordingly, Slt2 activation by HU,
MMS and UV radiation was analyzed in cells arrested in
G1 with a-factor and cells arrested in G2/M by inacti-
vating the CDC20 gene (Figure 5A). A mild Slt2 activa-
tion was observed in G1 cells treated with HU. By
Figure 5 Analysis of the cell cycle dependent activation of Slt2 by genotoxic stress. A) Exponentially growing cells of the wild type strain
(W303-1a) were arrested in G1 by incubation in the presence of 5 μg/mL a-factor for 2 hours. Exponentially growing cells of the GAL1:CDC20
strain (JCY1645) were arrested in metaphase by incubation in YPD medium for 3 hours. Cell cycle arrest was confirmed by cell morphology
(more than 95% of unbudded cells or more than 90% of large budded cells respectively) and analysis of DNA content by flow cytometry (lower
panels). Once arrested, cells were incubated for 60 min in the absence or presence of 200 mM hydroxyurea or 0,04% MMS, or were exposed to
UV radiation (50 J/m
2), while maintaing cell cycle arrest with a-factor or glucose. In the case of a-factor arrested cells, 600 mM HU, 0.12% MMS
and 150 J/m
2 UV radiation was used. The level of phosphorylated Slt2, total Slt2 protein and the chekpoint kinase Rad53 was determined by
western analysis. The ponceau staining of the membranes are shown as loading control. B) Slt2 activation by HU in metaphase arrested cells of
the GAL1:CDC20 strain (JCY1645) and a rho
0 strain derived from it were analysed as described in A.
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due to incubation of cells with MMS or UV irradiation
was detected in G1 cells; however, it has to be noted
that a-factor caused Slt2 activation, which could pre-
clude genotoxic-induced Slt2 activation. In G2/M cells,
no activation was observed in the presence of MMS or
after UV irradiation in contrast to what was detected in
cycling cells. These results suggest that Slt2 activation
by MMS or UV radiation probably occurs during the S
phase. On the contrary, Slt2 was activated by HU in
G2/M cells. We wondered whether Slt2 activation by
HU could be related to mitochondrial DNA replication;
however, the fact that Slt2 activation is also observed in
a rho
0 derived strain ruled out this possibility (Figure
5B). HU is an inhibitor of ribonucleotide reductase,
which catalyzes the limiting step in dNTP biosynthesis.
Incubation of cells with HU causes a reduction of dNTP
pools and a consequent blockage of S phase progression.
The fact that HU affects Slt2 activity in post-replicative
cells suggests that Slt2 activation could be, at least in
part, a direct response to an alteration of the nucleotide
pools, which also could indicate that Slt2 might be
involved in the control of dNTP pools.
Analysis of dNTP pools in the absence of Slt2
In an initial approach to characterize whether Slt2 could
affect dNTP pools, we first analyzed the ribonucleotide
reductase protein levels in slt2 cells in normal condi-
tions or after induction of DNA damage. A Western
blot analysis revealed that all the ribonucleotide reduc-
tase subunits were expressed at a similar level in wild-
type and slt2 c e l l sb o t hb e f o r ea n da f t e rH Uo rM M S
treatments (Figure 6A). It is possible that ribonucleotide
reductase activity could be defective in slt2 mutant cells
despite the amount of ribonucleotide reductase enzyme
not being altered. To test this, we measured the cellular
content of dATP, dCTP and dGTP in the wild-type and
slt2 mutant strains. As observed in Figure 6B, inactiva-
tion of Slt2 caused no significant changes in the concen-
tration of the three dNTPs under both basal conditions
and in MMS-treated cells. This result demonstrates that
Slt2 is not involved in the control of dNTP pools.
Analysis of DNA-integrity checkpoint activation in the slt2
mutant strain
In mammalian cells, p38 and ERK1,2 MAPKs are
involved in establishing the cell cycle checkpoint after
DNA damage [32,39-42]. Accordingly, we investigated
whether MAPK Slt2 was required to arrest cell cycle
progression after the induction of a replicative stress
with HU. After 6 hours, wild-type cells were blocked in
the G2/M phase, as deduced from the accumulation of
dumbbell cells characterized by a large bud similar in
size to the mother cell and a single nucleus close to the
bud neck. As seen in Figure 7A, the slt2 mutant strain
also accumulated nearly 80% of the large-budded cells,
similarly to what observed in the wild-type strain.
Nevertheless, it is noteworthy that a significant amount
of the arrested cells have somewhat elongated buds
(26.3 ± 3.5% in slt2 compared to 5.6 ± 1.2% in the wild-
type). These observations indicate that Slt2 is not
required for HU-induced cell cycle arrest, but is
Figure 3 Analysis of the hypersensitivity of slt2 cells to
genotoxic stress and the activation of Slt2 by genotoxic stress
in osmotically supported medium. A) 10-fold serial dilutions from
exponentially growing cultures of wild type (W303-1a) and slt2
(JCY1062) strains were spotted onto YPD medium containing 1 M
sorbitol and 200 mM hydroxyurea or 0.03% MMS or were exposed
to UV radiation (40 J/m
2). Plates were incubated at 25°C for 3 days.
B) Cultures of the wild type W303-1a strain grown on YPD
containing 1 M sorbitol were split and incubated for 60 min in the
absence or presence of 200 mM hydroxyurea, 0.04% MMS or 5 μg/
mL phleomycin, or were irradiated with UV radiation (50 J/m
2). The
level of phosphorylated Slt2 and the chekpoint kinase Rad53 (as a
control of the presence of genotoxic stress) was determined by
western analysis. The ponceau staining of the membrane is shown
as loading control.
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DNA damage.
We also analyzed cell cycle arrest after inducing DNA
damage with MMS. In this case, there was no homoge-
nous terminal morphology, but cell cycle arrest was
revealed by the DNA content analysis, showing a clear
accumulation of cells with non-replicated DNA after a
1-hour incubation in the presence of MMS. Importantly,
this accumulation was observed in both the wild-type
and the slt2 mutant strains (Figure 7B). Thus, MMS-
induced cell cycle arrest occurs in the absence of Slt2.
Finally, we also investigated whether checkpoint acti-
vation normally occurs in the absence of Slt2. To test
this, slt2 mutant cells were subjected to replicative stress
or DNA damage by incubation with HU or MMS,
respectively, and the presence of phosphorylated Rad53,
as indicative of checkpoint activation, was analysed by
Western blot. The results showed that phosphorylated
Rad53 accumulated at similar levels in the wild-type and
slt2 mutant strains after genotoxic treatments (Figure
7C). Thus, the DNA damage checkpoint is functional in
the absence of Slt2, at least until the Rad53 activation
step.
Slt2 has a pseudo-kinase paralog in yeast, protein
Mlp1. Mlp1 shares a function with Slt2 in transcrip-
tional activation [23]. Therefore, it is possible that Mlp1
could be functionally redundant with Slt2, and that it
could activate the DNA integrity checkpoint in the
absence of Slt2. However, we detected a proper activa-
tion of Rad53 by HU and MMS in the mlp1 and slt2
mlp1 mutant strains (Figure 7C). This observation con-
firms that Slt2 kinase and its relative Mlp1 protein are
not required for proper Rad53 activation.
Increasing evidence indicates there are cross-talks
between the MAPK cascades in yeast. Hog1, the MAPK
involved in the response to osmotic stress, is especially
interesting because recent works have related the Slt2
and Hog1 functions in the activation of the cell wall
gene expression [29]. Furthermore, Hog1 is the yeast
homolog to mammalian p38 MAPK. As mentioned
above, p38 plays an important role in cell cycle check-
points in response to DNA damage. Therefore, we
investigated whether Hog1 was involved in Rad53 acti-
vation. However, this was not the case because phos-
phorylated Rad53 normally accumulated after HU and
MMS treatments in the absence of Hog1 (Figure 7C).
Moreover, no defect in Rad53 activation was detected in
a slt2 hog1 double mutant, which ruled out any func-
tional redundancy between Slt2 and Hog1 in checkpoint
activation.
Slt2 is required for the proper degradation of Swe1 after
DNA damage
Recently, a morphogenetic function for the DNA integ-
rity checkpoint has been described, which consists in
switching off bud apical growth after damage [11]. This
is achieved by the degradation of CDK inhibitor kinase
Swe1. Cells with a defective checkpoint are unable to
degrade Swe1 and as a consequence, they cannot induce
the switch from polar to isotropic bud growth, resulting
in the formation of elongated buds. By considering that
Slt2 has been related to Swe1 regulation [26,27] and
that slt2 mutant cells manifested a hyperpolarization
defect in response to DNA damage, we wondered
whether Slt2 is required for the morphogenetic response
controlled by the Rad53 checkpoint kinase. To
Figure 4 Activation of Slt2 by genotoxic stress in DNA integrity checkpoint mutants. Exponentially growing cultures of the wild type
(W303-1a), sml1 (JCY1144), rad53 sml1 (JCY1038), mec1 sml1 (JCY1039), mec1 tel1 sml1 (JCY1275) and tel1 (JCY1258) strains were split and
incubated for 60 min in the absence or presence of 200 mM hydroxyurea or 0.04% MMS. Exponentially growing cultures of the tetO7:RAD53
(JCY1149) strain were incubated for 6 hours in the absence or presence of 5 μg/mL doxicycline in order to repress the tetO7 promoter followed
by 60 min incubation in the absence or presence of 200 mM hydroxyurea. The level of phosphorylated Slt2, total Slt2 protein and the chekpoint
kinase Rad53 was determined by western analysis. The ponceau staining of the membranes are shown as loading control.
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after incubating cells with HU (Figure 8). As previously
described, Swe1 is eliminated from wild-type cells after
genotoxic stress to reduce to less than 20% of the initial
protein level after 6 hours. It is remarkable to note that
Swe1 protein decay was minimized in the absence of
Slt2, and that more than 50% of the initial protein
remained after 6 hours. This was not caused by cell
cycle effects, as cell cycle distribution of slt2 mutant was
roughly similar to that of wild type strain (see Figure
7A) neither to differences in checkpoint activation as
Rad53 phosphorylation occurred with similar kinetics.
This result indicates that Slt2 is involved in the morpho-
genetic response after DNA damage and is required for
optimal Swe1 degradation in response to DNA damage.
Interestingly, hyperpolarization of slt2 mutant cells is
not observed when Swe1 kinase is inactivated (Figure
8B). This demonstrates that Slt2 control of bud mor-
phogenesis in response to DNA damage is mediated by
the Swe1 kinase. However, Slt2 inactivation caused loss
of cell viability even in the absence of Swe1 (Figure 8C),
indicating that the hipersensitivity to genotoxic stresses
involves additional Swe1-independent mechanisms.
Discussion
Activation of cell-cycle checkpoints in response to var-
ious types of DNA damage is essential for the mainte-
nance of genomic stability in eukaryotic cells. This work
describes how the Slt2 MAP kinase is activated in
response to DNA damage and that Slt2 is essential to
properly cope with genotoxic stresses. Slt2 is involved in
cell wall assembly and is activated by cell wall damage,
so it could be possible that slt2 mutant hypersensitivity
to genotoxic treatments or Slt2 activation simply result
from increased cell wall permeability or unknown cell
wall damage caused by the treatments. This possibility is
unlikely, however, because hypersensitivity to genotoxic
treatments is also observed in the presence of sorbitol,
which indicates that cell death is not related to cell wall
defects. Most remarkably, Slt2 activation after induction
o fas i n g l eD S Bi nt h eGAL1:HO strain, a process that
has a specific effect on DNA integrity and is not related
to cell wall, strongly supports a genuine role for Slt2 in
the response to genotoxic stress. This conclusion is also
reinforced by a recent genetic interaction network analy-
sis that connected Slt2 to the cellular response to MMS
[44]. It is important to note that both Slt2 activation
and hypersensitivity of the slt2 mutant are observed in
response to a wide range of genotoxic stresses, which
result in different types of DNA damage: e.g., DSB, thy-
midine dimers, nucleotide alkylation or replicative forks
stalling. This reinforces the importance of Slt2 in the
response to genotoxic stresses and suggests that Slt2
could play a common role in the response to different
types of damage.
Response to DNA damage is primarily governed by
the activation of the DNA-integrity checkpoints. How-
ever, Slt2 is activated even in the absence of a functional
checkpoint, indicating that genotoxic stress is trans-
duced to the Slt2 kinase by a checkpoint-independent
mechanism. In fact, Slt2 activation and Rad53 activation
after inducing DNA damage occur independently of
each other. Thus, both kinases appear to fulfill comple-
mentary functions necessary for cell survival in parallel
Figure 6 Analysis of ribonucleotide reductase (RNR) function in
the slt2 mutant strain. A) Exponentially growing cultures of the
wild type W303-1a strain were split and incubated for 120 min in
the absence or presence of 200 mM hydroxyurea or 0.04% MMS.
The protein level of the different subunits of the RNR enzyme was
analyzed by western blot. A non-specific band labelled with an
asterisk that cross-react with the antibody is shown as loading
control. B) Exponentially growing cultures of the wild type W303-1a
strain were split and incubated for 120 min in the absence or
presence of 0,04% MMS. The cellular content of dATP, dCTP and
dGTP were determined in crude cell extracts. Similar results were
obtained with cells incubated for 60 min in the presence of HU or
MMS.
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Page 8 of 14independent DNA-damage signaling pathways. This
indicates that the response of yeast cells to genotoxic
stresses could be more complex than previously sus-
pected, and may involve new crucial players like Slt2
MAPK. In mammalian cells, p38 MAPK activation in
response to DNA damage has been reported to be
dependent on ATM/ATR checkpoint kinases in some
cases; however, in addition to the checkpoint pathway,
other mechanisms still to be established activate p38
MAPK in response to DNA damage [32]. Thus, a
mechanism directly linking MAPK activation to DNA
damage could be conserved in eukaryotic cells.
It is not clear how genotoxic stresses could activate
Slt2. We have observed that upregulation of Slt2 is
Figure 7 Functional analysis of the DNA integrity checkpoint in the slt2 mutant strain. A) Exponentially growing cultures of the wild type
(W303-1a) and slt2 (JCY1062) strains were split and incubated for the indicated time in the absence or presence of 200 mM hydroxyurea. Cell
cycle distribution of cells was analyzed determining cellular morphology and number of nuclei by microscopy. Cells were classified as unbudded,
budded with a single nucleus, budded with two nucleus and dumbble-like cells (cells with a large bud similar in size to mother cells but with a
single nucleus), which are indicative of G2/M cell cycle arrest. The presence of dumbble cells with an abnormal elongated bud is also indicated.
Graphs represent cell distribution derived from at least three independent cultures. No change in cell distribution was observed in untreated
controls at 6 hours incubation time. Pictures correspond to the HU-treated sample at 8 hours incubation time. B) Analysis of the DNA content by
flow cytometry of samples from exponentially growing cultures of the wild type (W303-1a) and slt2 (JCY1062) strains incubated for 60 min in the
absence or presence of 0.04% MMS. C) Exponentially growing cultures of the wild type (W303-1a), slt2 (JCY1062), mlp1 (JCY1334), slt2 mlp1
(JCY1336), hog1 (JCY1489) and slt2 hog1 (JCY1606) strains were split and incubated for 60 min in the absence or presence of 200 mM
hydroxyurea or 0,04% MMS. Activation of the chekpoint kinase Rad53 was determined by western analysis. The ponceau staining of the
membrane is shown as loading control.
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mechanism. As commented above, Slt2 activation occurs
in osmotically supported cells or in cdc42 mutant cells
that cannot bud [43] and it was observed after specific
induction of a single DSB, which strongly suggests that
Slt2 activation is not an indirect effect. The observed
Slt2 activation could be a direct result of DNA lesions.
Remarkably, however, Slt2 activation by MMS and UV
is cell cycle-regulated since it does not occur in the cells
a r r e s t e di nG 2 / M .T h i ss u g g e s t st h a tS l t 2d o e sn o t
respond to primary damage and should be related to
alterations that appear as damaged cells progress
through the cell cycle.
Activation by HU seems to be a different case since
HU induced Slt2 activation, even in G2/M-arrested
cells. It could be expected that HU stress would only
affect cells that were actively replicating DNA. The fact
that HU induced activation is also observed in post-
replicative cells, i.e., cells that do not consume dNTP
pools, suggests that Slt2 could respond directly to the
inhibition of ribonucleotide reductase activity and the
reduction in dNTP pool levels. Very recently, Slt2 has
been suggested to repress the expression of the
RNR1,2,3 genes, as deduced from the increase in
mRNAs observed in the slt2 mutant strain [44]. How-
ever, we detected no change in the protein level in any
ribonucleotide reductase subunit after Slt2 inactivation
in both untreated and MMS-treated cells. More impor-
tantly, dNTP pools, which reflect the physiological func-
tion of ribonucleotide reductase activity, were not
altered in the slt2 mutant under any analyzed condition.
Thus, our results argue against a role of Slt2 in control-
ling ribonucleotide reductase and dNTP pools.
Our findings show that Slt2 plays an important part in
the general cellular response to genotoxic stress. Slt2
could mediate a defensive mechanism developed by
Figure 8 Analysis of Swe1 protein level in slt2 mutant cells after a replicative stress. A) Exponentially growing cells of the wild type
(JCY1316) and slt2 (JCY1318) strains expressing a HA-epitope tagged Swe1 protein were incubated in the absence or presence of 200 mM
hydroxyurea. Swe1 protein level and activation of the chekpoint kinase Rad53 was analyzed at the indicated time after the addition of HU by
western blot. A non-specific band labelled with an asterisk that cross-react with the antibody is shown as loading control. Graph represents the
relative amount of Swe1 protein related to the non-specific band in the HU-treated cells derived from three independent assays. B) Exponentially
growing cultures of the slt2 (JCY1062) and the slt2 swe1 (JCY1633) strains were incubated in the presence of 200 mM hydroxyurea for 6 hours.
Cell cycle distribution of cells and the presence of abnormal elongated bud were analyzed as described in Figure 7. Graphs represent cell
distribution derived from at least three independent cultures. C) Aliquots from exponentially growing cultures of the swe1 (JCY1632) and the slt2
swe1 (JCY1633) strains were incubated for 90 min. at the indicated doses of HU, MMS and phleomycin or were exposed to different doses of UV
radiation. Cells were plated on YPD and the percentage of surviving cells relative to untreated controls was determined.
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rity. Primary cellular defense to DNA damage involves
cell cycle arrest to facilitate DNA repair prior to pro-
gression through the S phase or mitosis. It is known
that Slt2 contributes to the delay of the G2/M transition
in response to actin stress [26,27]. However, this is not
the case in the response to genotoxic stress since cell
cycle arrest occurs in the absence of Slt2. Alternatively,
it is tempting to speculate that Slt2 could directly favour
DNA damage repair. On the other hand, involvement of
Slt2 in the response to genotoxic stress could be related
with its known function in cell morphogenesis, the actin
cytoskeleton and cell integrity. Although this idea may
seem surprising, there is increasing evidence for a direct
cross-talk between the DNA checkpoint pathway and
cellular morphogenesis. Thus, various checkpoint pro-
teins contribute to cell wall architecture and mainte-
nance of cell polarity [11], Cdk1 regulates Rad53 to
orchestrate cellular morphogenesis during cell cycle
[49], Rad53 interacts with septins in the bud neck and
directs filamentous differentiation in response to geno-
toxic stress [50], Rad53 phosphorylates Slt2 to control
the Slt2-dependent expression of the cell wall FKS2
gene in response to caffeine [51], the Mdt1 protein has
partially separable functions in both the cell wall and
genome integrity pathways [52], and we have observed a
synthetic lethality between slt2 and rad53 mutations
that is suppressed by sorbitol, which suggests that leth-
ality is caused by a morphogenetic defect. In fact, bud
morphogenesis control has been described as an output
of DNA replication checkpoint activation [11], which
clearly demonstrates the link between genome mainte-
nance and cell morphogenesis. We have observed that
Slt2 is related to the morphogenetic aspects of the repli-
cative stress response. In budding yeast cells, actin
cytoskeleton polarization has to be regulated during
DNA damage-induced cell cycle arrest to maintain bud
morphogenesis. Thus during the response to DNA
damage, checkpoint activation has been described to
cause degradation of the Swe1 kinase [11], which is the
main protein involved in the morphogenesis checkpoint
controlling bud growth [8,9]. This leads to the activation
of the Clb1,2-Cdc28 kinases, which are responsible for
the switch from apical to isotropic bud growth, an
essential switch for proper bud morphogenesis [12,13].
We have observed that Swe1 degradation after replica-
tive stress is partially impaired in the absence of Slt2,
causing altered bud morphogenesis in slt2 cells. Defects
in Swe1 degradation has been related to HU sensitivity
[10], which could explain slt2 phenotype. However, HU
and other genotoxic treatments caused a reduced viabi-
lity of slt2 mutant cells even in the absence of Swe1,
which indicates that Slt2 must affect cell viability by a
Swe1-independent mechanism. How Slt2 influences
Swe1 stability is intriguing, and even more so if we con-
sider that this effect is apparently contradictory to the
results previously described in the morphogenesis
checkpoint context [26] or in response to Ca
2+ [53]. In
these cases, Slt2 acts by activating Swe1 or by repressing
Mih1 to inhibit Cdc28 kinase activity, whereas in the
response to replicative stress, Slt2 seems to act by inac-
tivating Swe1 to induce Cdc28 kinase activity. Elucidat-
ing the molecular basis of the Slt2 function in the
response to genotoxic stresses will help explain this
apparent contradiction and to gain insight into the
molecular link between cellular morphogenesis and
integrity with genome integrity maintenance.
Conclusions
Our results support a function of MAPK Slt2 in the
maintenance of DNA integrity. Inactivation of Slt2
results in hypersensitivity to many types of genotoxic
treatments. Moreover, Slt2 is activated by several geno-
toxic stresses. These results suggest that Slt2 play an
important role in the cellular response to DNA damage.
Slt2 activation by MMS and UV, but not HU, requires
cell cycle progression. Slt2 is not involved in dNTP
pools regulation and is not required for DNA-damage
induced cell cycle arrest or checkpoint activation.
Nevertheless, Slt2 function is important for bud mor-
phogenesis control and optimal Swe1 degradation under
replicative stress. The results described here point to the
MAPK Slt2 as a new player in the cellular response to
genotoxic stresses.
Methods
Strains and growth conditions
The yeast strains used in this study are shown in Table
1. The slt2::TRP1, sml1::kanMX6, tel1::kanMX6, mlp1::
kanMX6, hog1::kanMX4, swe1::kanMX6 and SWE1-HA-
kanMX6 cassettes were amplified from pFA6a series
plasmids (a gift from Dr. J.R. Pringle) or Euroscarf yeast
strains and integrated in the indicated parental strain.
The substitution of the RAD53 promoter by the tetO7
promoter was obtained by integrating a DNA fragment
amplified from plasmid pCM225 (a gift from E. Her-
rero). To obtain the JCY1645 strain, a plasmid contain-
ing the GAL1:CDC20 gene (a gift from E. Queralt) was
digested with McsI and integrated in W303-1a. To
obtain a rho
0 strain derived from JCY1645, cells were
grown to saturation in the presence of 25 g/mL ethi-
dium bromide and streaked for single colonies. The loss
of mitochondrial DNA was checked by the failure to
grow on medium containing glycerol as sole carbon
source and by fluorescence microscopy analysis of
DAPI-stained cells. Cells were grown on standard yeast
extract-peptone-dextrose (YPD). For growth assays, 10-
fold serial dilutions in growth medium were prepared
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6
cells/mL) of the different strains. 5 μL of each dilution
was then spotted onto YPD, YPD supplemented with
100 mM hydroxyurea (HU), 0.025% methyl metanosul-
fonate (MMS) or 5 μg/mL phleomycin and YPD fol-
lowed by UV irradiation (35 J/m
2)u s i n gt h eG SG e n e
Linker™ UV chamber (Bio-Rad). 1 M sorbitol was
added to the growth media when required. For induc-
tion of genotoxic stress in liquid cultures, 0.2-0.4 M
HU, 0.04% MMS or 5 μg/mL phleomycin was added to
exponentially growing cultures or cells were exposed to
UV irradiation (50 J/m
2). For induction of a single DSB
the GAL1:HO strain was grown overnight on yeast
extract-peptone-2% raffinose medium, then 2% galactose
(or 2% glucose as a negative control) was added to the
medium and cells were incubated for 4 hours. Cell cycle
arrest at G1 phase was accomplished by the addition of
5 μg/ml a-factor and incubation for 3 hours,. Cell cycle
arrest at G2/M phase was accomplished by growing
GAL1:CDC20 cells in yeast extract-peptone-2% galactose
medium (plus 0.1% glucose in the case of the rho
0
strain) and transferring them to YPD for 3 hours, pre-
viously to the genotoxic treatments. To repress the
tetO7 promoter, doxycicline was added to a final con-
centration of 5 μg/mL.
Western blot analysis
Approximately 10
8 cells were collected, resuspended in
100 μl water and, after adding 100 μl 0.2 M NaOH, they
were incubated for 5 min at room temperature. Cells
were collected by centrifugation, resuspended in 50 μl
sample buffer and incubated for 5 min at 95°C. Extracts
were clarified by centrifugation, and equivalent amounts
of protein were resolved in an SDS-PAGE gel and trans-
ferred onto a nitrocellulose membrane. The primary
antibodies used in this study include anti-fosfo-44/42
Map kinasa Thr200/Tyr204 (Cell Signalling) to detect
activated Slt2, anti Mpk1-yC20 (Santa Cruz Biotechnol-
ogy) to detect total Slt2 protein, anti Rad53-YC19 (Santa
Cruz Biotechnology), anti-HA 3F10 monoclonal anti-
body (Roche), and anti Rnr1, Rnr2, Rnr3 and Rnr4
(kindly provided by M. Huang, University of Colorado).
Blots were developed with HRP-labeled secondary anti-
bodies using the ECL Advance Western Blotting Detec-
tion Kit (GE Healthcare Life Sciences). Bands were
quantified with a ImageQuant™ LAS 4000mini biomo-
lecular imager (GE Healthcare).
dATP, dCTP and dGTP measurements
Approximately 2 × 10
8 cells were harvested, washed
with water, resuspended in 200 μLo fc o l d6 0 %m e t h a -
nol, and extracts obtained by vigorous shacking in the
presence of glass beads. Then, cell debris was pelleted at
27000 g for 1 min, and the supernatant was held at -20°
C for 2 h. The samples were boiled for 3 min, and fol-
lowed by centrifugation at 13000 g for 10 min at 4°C.
The supernatant was taken to dryness under vacuum
and resuspended in 40 μL of water. The dATP, dCTP
and dGTP levels were determined by the DNA polymer-
ase-based enzymatic assay [54]. Briefly, the
Table 1 Yeast strains
W303-1a MATa ade2-1 trp1-1 leu2-3,112 his3-11,15 ura3-52 can1 rad5-535
SEY6211 MATa ade2-101 trp1-Δ902 leu2-3,112 his3-Δ200 ura3-52 RAD5
JKM139
a MATa ade1-100 trp1-1 leu2-3,112 lys5 ura3-52 trp1::hisG hoΔ hml::ADE1 hmr::ADE1 ade3::GAL-HO RAD5
JCY193 slt2::LEU2 in SEY6211
JCY1038
b rad53::HIS3 sml1-1 in W303-1a
JCY1039
b mec1::TRP1 sml1::HIS3 in W303-1a
JCY1062 slt2::TRP1 in W303-1a
JCY1144 sml1::kanMX6 in W303-1a
JCY1149 tTR’::LEU2 tetO7::RAD53-kanMX4 in W303-1a
JCY1258 tel1:: kanMX6 in W303-1a
JCY1275 tel1:: kanMX6 in JCY1039
JCY1316 SWE1-HA-kanMX6 in W303-1a
JCY1318 SWE1-HA-kanMX6 in JCY1062
JCY1334 mlp1::kanMX6 in W303-1a
JCY1336 mlp1::kanMX6 in JCY1062
JCY1489 hog1::kanMX4 in W303-1a
JCY1616 hog1::kanMX4 in JCY1062
JCY1632 swe1::kanMX6 in W303-1a
JCY1633 swe1::kanMX6 in JCY1062
JCY1645 GAL1:CDC20-TRP1 in W303-1a
a from Dr. J.E. Haber; from
b Dr. J. Torres
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dCTP and dGTP into specific oligonucleotides contain-
ing poly(AAAT), poly(AAAG) or poly(AAAC) sequences
respectively, was determined in the presence of excess
[
3H]dTTP.
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